JUSTIN SHEPHERD: Open Payments
NPI 1205340247 · RICH SQUARE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 23 payments from 8 companies in 2025. Trend: 2023 $655 · 2024 $588 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $232 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $160 |
| Corcept Therapeutics | 3 | $59 |
| PFIZER INC. | 2 | $30 |
| Novo Nordisk Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 2 | $13 |
Products named: Kerendia, FARXIGA, BREZTRI, Korlym, AIRSUPRA, Rybelsus, Dexcom G6 Transmitter, PREVNAR 20.
Industry payments across NC — which companies pay providers there.
